Episode 1: The Bio-Health Supercycle

The companies that will create SpaceX-scale wealth in bio-health will not discover the next blockbuster drug. They are the ones that will reduce the cost of discovering, manufacturing, or delivering any drug by an order of magnitude, making the entire platform cheaper, faster, and more accessible, exactly as AWS made software cheaper, TSMC made chips cheaper, and SpaceX made orbit cheaper. This is the beginning of a new series of episodes exploring where the next wealth creators will emerge from in pharma.Listen in! This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com